An official website of the United States government Here's how you know

U.S. Department of Health and Human Services | National Institutes of Health

Official websites use .gov
A .gov website belongs to an official government
organization in the United States.

Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.

56th Meeting of the National Institutes of Health Advisory Committee on Research on Women's Health

Event Details

Description of Event

Virtual only.

2022-04-06T20:00:00Z 2022-04-06T13:30:00Z Event Information

Videocast Link: https://videocast.nih.gov/watch=45020

Agenda

9:30–9:45 a.m.	Call to Order	Samia Noursi, Ph.D. Executive Secretary, Advisory Committee on Women's Health Research (ACRWH) Associate Director, Science Policy, Planning, and Analysis, Office of Research on Women's Health (ORWH), National Institutes of Health (NIH)
9:45–10:45 a.m.	ORWH Director's Report	Janine A. Clayton, M.D., FARVO Associate Director for Research on Women’s Health, NIH Director, ORWH, NIH
10:45–11:45 a.m.	NHLBI Director's Report	Gary H. Gibbons, M. D. Director, National Heart, Lung, and Blood Institute (NHLBI), NIH
11:45 a.m.–12:15 p.m.	NIH Inclusion Update	Dawn Corbett Inclusion Policy Officer, Office of Extramural Research (OER), NIH
12:15 p.m.	Virtual Group Photo
12:15–1:00 p.m.	BREAK
1:00–1:30 p.m.	2021 Women's Health Conference: Updates and Next Steps	Sarah Temkin, M.D. Associate Director for Clinical Research, ORWH, NIH
1:30–2:00 p.m.	Continuity Supplements Reissuance: Concept Clearance	Xenia Tigno, Ph.D. Associate Director for Careers, ORWH, NIH
2:00–2:30 p.m.	Sex and Gender R01 Reissuance: Concept Clearance	Chyren Hunter, Ph.D. Associate Director for Basic and Translational Research, ORWH, NIH
2:30–3:00 p.m.	Galvanizing Health Equity through Novel and Diverse Educational Resources (GENDER) R25 program: Concept Clearance	Sarah Temkin, M.D. Elizabeth Barr, Ph.D. Social and Behavioral Scientist Administrator; ORWH, NIH
3:30–4:30 p.m.	Open Discussion	Janine A. Clayton, M.D., FARVO
4:30–4:35 p.m.	Closing Statement	Janine A. Clayton, M.D., FARVO

America/New_York